Riskpilot← Back to searchSign inGet full accessMEDICUS STAVANGER AS
ASActiveOrg 919659327Haakon VIIs gate 7, 4005 StavangerMedical specialists activities · NACE 8622Est. 201711 employees
Revenue 2024
NOK 24,4M
-1% vs 2023
EBITDA margin
10.8%
+2601% vs 2023
Equity ratio
45.6%
Financial strength
Net profit 2024
NOK 1,6M
+352% vs 2023
| Revenue | NOK 24,4M | -1% |
| EBITDA | NOK 2,6M | +2601% |
| Net profit | NOK 1,6M | +352% |
| Total assets | NOK 12,3M | +27% |
| Equity | NOK 5,6M | -3% |
| Employees | 11 | — |
Legal name
MEDICUS STAVANGER AS
Org number
919659327
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
3. oktober 2017
Share capital
NOK 103 500
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Tilby helsetjenester til pasienter, firmaer, institusjoner og andre, herunder å etablere nye helsetilbud, forretningsvirksomhet inkludert, samt å drive eller delta i kliniske utprøvinger innen det medisinske fagområdet, investere i fast eiendom og verdipapirer, og delta i andre selskaper med økonomisk formål.
Address
Haakon VIIs gate 7, 4005 Stavanger
Phone
+4751524000
Email
post@medicus.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 744 | 21 145 | 24 405 | 24 600 | 24 380 |
| Staff expenses | −4 879 | −6 728 | −8 842 | −11 570 | −9 857 |
| EBITDA | 1 393 | 3 239 | 587 | −105 | 2 634 |
| Depreciation & amort. | −130 | −715 | −914 | −665 | −585 |
| EBIT | 1 263 | 2 524 | −326 | −770 | 2 050 |
| Net financials | −85 | −39 | −160 | −49 | 14 |
| Profit before tax | 1 178 | 2 485 | −487 | −820 | 2 064 |
| Tax | −619 | 596 | −107 | −180 | 455 |
| Net profit | 1 797 | 1 889 | −380 | −639 | 1 608 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 906 | 13 034 | 11 532 | 9 719 | 12 342 |
| Equity | −683 | 5 706 | 5 979 | 5 809 | 5 630 |
| Long-term debt | 1 800 | 3 913 | 1 717 | 1 039 | 208 |
| Short-term debt | 2 790 | 3 416 | 3 837 | 2 871 | 6 504 |
| Total debt | 4 590 | 7 328 | 5 554 | 3 910 | 6 712 |
EBITDA margin
10.8%
This company
15.8%
Market median
-32% vs market
20202024
Equity ratio
45.6%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
28.6%
This company
18.4%
Market median
+55% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
1.98×
This company
1.12×
Market median
+77% vs market
20202024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skeiseid-Klefstad Holding As
MEDICUS STAVANGER AS Board members of MEDICUS STAVANGER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|